Keyphrases
Radiotherapy
100%
Local Control
100%
Concurrent Chemoradiotherapy
100%
Chemoradiotherapy
100%
Extrahepatic Cholangiocarcinoma
100%
Surgical Morbidity
100%
Distant Failure
100%
Survivors
50%
Chemotherapy
50%
Treatment Strategy
50%
5-year Survival
50%
Advanced Disease
50%
Long-term Survival
50%
Improved Survival
50%
Adjuvant Radiotherapy
50%
Systemic Therapy
50%
Resection
50%
Median Survival
50%
Retrospective Analysis
50%
Overall Survival
50%
Rare Malignancy
50%
Survival Benefit
50%
Univariate Analysis
50%
Disease-free Survival
50%
Tumor Resectability
50%
Fluoropyrimidine-based Chemotherapy
50%
Local Failure
50%
Failure Pattern
50%
Perineural Involvement
50%
Postoperative Setting
50%
Survival Outcomes
50%
Radical Resection
50%
Metastasis-free Survival
50%
R0 Resection
50%
Biliary Cancer
50%
Locoregional Control Rate
50%
Control Benefits
50%
Medicine and Dentistry
Chemoradiotherapy
100%
Cholangiocarcinoma
100%
Disease
50%
Radiation Therapy
50%
Surgery
50%
Chemotherapy
50%
Neoplasm
25%
Cancer
25%
Adjuvant Radiotherapy
25%
Systemic Therapy
25%
Overall Survival
25%
Univariate Analysis
25%
Disease Free Survival
25%
Bile Duct Cancer
25%
Metastasis Free Survival
25%
Radical Resection
25%
Fluoropyrimidine
25%
Pharmacology, Toxicology and Pharmaceutical Science
Chemoradiation Therapy
100%
Bile Duct Carcinoma
100%
Disease
50%
Chemotherapy
50%
Neoplasm
25%
Overall Survival
25%
Disease Free Survival
25%
Bile Duct Cancer
25%
Fluoropyrimidine
25%
Metastasis Free Survival
25%